Therefore, it may be a possible target in the pharmaco-therapeutic treatment of obesity and its complications.5,26 Handisurya et al. reported that weight loss following gastric bypass decreased BMI and vaspin hormones in morbidly obese subjects after 12 months. The gene discussed is SERPINA12; the disease is Obesity.